Loading…
Surgery Partners, Inc. is projected to rise to $18.72 by 2027, a +18% move from its current price of $15.90. SGRY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $15.46 | $15.90 | $16.36 | +0.02% |
| Aug 2 | $15.28 | $15.91 | $16.56 | +0.05% |
| Aug 3 | $15.14 | $15.91 | $16.72 | +0.07% |
| Aug 4 | $15.03 | $15.92 | $16.85 | +0.10% |
| Aug 5 | $14.93 | $15.92 | $16.97 | +0.12% |
| Aug 6 | $14.85 | $15.92 | $17.08 | +0.15% |
| Aug 7 | $14.77 | $15.93 | $17.18 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.77 | $15.93 | $17.18 | +0.17% |
| Week 2 | $14.34 | $15.95 | $17.75 | +0.34% |
| Week 3 | $14.02 | $15.98 | $18.22 | +0.52% |
| Week 4 | $13.76 | $16.01 | $18.62 | +0.69% |
| Week 5 | $13.54 | $16.04 | $18.99 | +0.86% |
| Week 6 | $13.35 | $16.06 | $19.33 | +1.04% |
| Week 7 | $13.18 | $16.09 | $19.65 | +1.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Surgery Partners, Inc. operates a network of surgical facilities and ancillary services across the United States. It provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in specialties including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
The company also runs emergency departments and ancillary services such as physician practices, diagnostic testing, multi-specialty physician practices, urgent care facilities, and anesthesia services. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners, Inc. (SGRY) is a healthcare company focused on owning and operating a network of surgical facilities and related services. Its current price is $16.41 and its market capitalization is $2.15B, with a market ranking of 1988.
A major floor 27.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.5% below — buyers have tended to step in here.
The nearest ceiling, 8.4% above — a clean break opens room to run.
A major ceiling 18.2% above — clearing it would confirm fresh momentum.
Key SGRY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SGRY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.76 | Buy | $15.85 | Buy |
| MA 10 | $15.75 | Buy | $15.83 | Buy |
| MA 20 | $16.11 | Sell | $15.81 | Buy |
| MA 50 | $15.09 | Buy | $15.33 | Buy |
| MA 100 | $14.18 | Buy | $15.10 | Buy |
| MA 200 | $15.48 | Buy | $16.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.51 | Neutral |
| Stoch RSI (14) | 46.80 | Neutral |
| CCI (20) | -25.62 | Neutral |
| Williams %R (14) | -48.68 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | 5.16 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 51.32 | Neutral |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 47.02 | Neutral |
| Momentum (10) | -0.74 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 15.93 | Sell |
| ADX (14) | 14.44 | Neutral |
| ATR (14) | 0.47 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60. The stock trades around key moving averages, with a SMA50 of $15.05 and a SMA200 of $15.50.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.49 | $15.90 | $20.78 | 0% | Neutral | |
| $14.87 | $18.72 | $24.96 | +18% | Neutral | |
| $15.00 | $19.46 | $26.99 | +22% | Bullish | |
| $16.49 | $21.93 | $31.34 | +38% | Bullish | |
| $17.91 | $24.33 | $35.66 | +53% | Bullish | |
| $22.21 | $30.78 | $46.13 | +94% | Bullish | |
| $26.50 | $37.40 | $57.18 | +135% | Bullish | |
| $25.34 | $36.38 | $56.63 | +129% | Bullish | |
| $26.34 | $38.44 | $60.82 | +142% | Bullish | |
| $29.31 | $43.45 | $69.82 | +173% | Bullish | |
| $43.05 | $68.53 | $117.39 | +331% | Bullish | |
| $82.96 | $149.39 | $280.76 | +840% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.49 | $15.90 | $18.56 | +0.00% |
| August 2026 | $13.95 | $16.38 | $19.71 | +3.05% |
| September 2026 | $13.72 | $16.26 | $19.83 | -0.76% |
| October 2026 | $13.29 | $15.86 | $19.56 | -2.48% |
| November 2026 | $13.44 | $16.14 | $20.08 | +1.77% |
| December 2026 | $13.72 | $16.56 | $20.78 | +2.63% |
Click any year to see its month-by-month SGRY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SGRY price prediction for 2026 points to an average of $15.90 (low $11.49, high $20.78) — a potential gain of 0% on today's $15.90. Price action looks broadly range-bound.
In 2027, SGRY is projected to trade between $14.87 and $24.96, averaging $18.72 — a potential gain of +18% from today's $15.90. That is up +18% on the projected 2026 average. A consolidation phase looks the most probable path here.
Surgery Partners, Inc.'s 2028 outlook centres on $19.46, within a $15.00 to $26.99 range. That is up +4% on the projected 2027 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2029, SGRY could reach as high as $31.34, with a base case around $21.93 and support toward $16.49 — roughly +38% from $15.90. Buyers look set to stay in control over this stretch.
Expect SGRY to range from $17.91 to $35.66 through 2030. The $24.33 average target implies a +53% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The SGRY price prediction for 2031 points to an average of $30.78 (low $22.21, high $46.13) — a potential gain of +94% on today's $15.90. Buyers look set to stay in control over this stretch.
In 2032, SGRY is projected to trade between $26.50 and $57.18, averaging $37.40 — a potential gain of +135% from today's $15.90. That is up +22% on the projected 2031 average. Momentum favours further upside here.
Surgery Partners, Inc.'s 2033 outlook centres on $36.38, within a $25.34 to $56.63 range. That is -3% versus the projected 2032 average. That marks a +129% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, SGRY could reach as high as $60.82, with a base case around $38.44 and support toward $26.34 — roughly +142% from $15.90. Momentum favours further upside here.
Expect SGRY to range from $29.31 to $69.82 through 2035. The $43.45 average target implies a +173% move from current prices. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The SGRY price prediction for 2040 points to an average of $68.53 (low $43.05, high $117.39) — a potential gain of +331% on today's $15.90. Momentum favours further upside here.
In 2050, SGRY is projected to trade between $82.96 and $280.76, averaging $149.39 — a potential gain of +840% from today's $15.90. That is up +118% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SGRY today (≈ 62.893082 SGRY) could be worth
$9,395.81
+$8,395.81 (+840%) by 2050 · US Dollar
Based on the average projected SGRY price of $149.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SGRYwould be worth at today's price.
$1,000 invested in SGRY on Jul 30, 2025 (≈ 44.702725 SGRY) would be worth
$710.77
-$289.23 (-28.9%) today · 0.71× · US Dollar
Based on a SGRY entry price of $22.37 vs. today's $15.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.22 | $1,044.68 | +4.5% |
| 1 month ago | $16.8 | $946.43 | -5.4% |
| 3 months ago | $14.27 | $1,114.23 | +11.4% |
| 6 months ago | $14.86 | $1,069.99 | +7.0% |
| 1 year ago | $22.37 | $710.77 | -28.9% |
| All time (5.0y) ago | $54.54 | $291.53 | -70.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SGRY forecast.
Our base-case forecast reaches $32.00 around 2032.
Implied market cap at $32.00: $4.19B
Forecasts project a pronounced long-run uptrend. In 2030, the average price is expected to be $25.65 with a ROI of 56.3% and bullish sentiment. By 2040, the average is $73.76 with a ROI of 349.5% and bullish sentiment, and by 2050, the average is $161.95 with a ROI of 886.9% and bullish sentiment.
The forecast path includes higher outer-range values in the 2026–2035 window and beyond, signaling substantial upside over the long term, while noting that these are estimates and not guarantees.
Tap a question to reveal the answer.
2030 forecast shows an average price of $25.65 with a 56.3% ROI and bullish sentiment; the range for 2030 is not provided beyond the average, min, and max in the data.
Long-run forecasts indicate strong upside, with 2040 and 2050 averages of $73.76 and $161.95 and ROIs of 349.5% and 886.9% respectively, though these are estimates and not guarantees.
Yes, the forecast includes a 2032 max of $60.67 and a 2033 max of $60.16, indicating near-$60 levels are plausible in the mid-2030s timeframe.
Current price is $16.41 and market cap is $2.15B; the rank is 1988.
The 2027 forecast shows an average price of $19.43 with a min of $15.42 and a max of $25.94, a ROI of 18.4%, and neutral sentiment.
Surgery Partners, Inc. Community Discussion
0Share your Surgery Partners, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.